Search

everythinglearnresearchcommunity

for

Search:↓

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

γδ T cells adapt uniquely to different tissues in mice.

AIMP1 can boost hair growth by increasing stem cell activity.

Boosting certain cell signals can prevent hair loss from cancer treatments.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

NFATc1 controls hair stem cell activity, affecting hair growth and could be a target for hair loss treatments.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Fetal skin has unique immune cells different from adult skin.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Regulatory T cells are essential for normal and improved wound healing in mice.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Moderate immune responses help hair growth, while excessive responses slow it down.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Activated LEF/TCF complexes are crucial for hair development and cycling.